VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLBT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLBTCellebrite DI Ltd.
$11.16$2.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLBTBalance Sheet

Cellebrite DI Ltd. (CLBT) Balance Sheet

7Y historyFree accessUpdated daily

Total debt of $23.4M against $579.3M of equity (debt-to-equity of roughly 0.04) and a current ratio between 1.53 and 2.11 suggest minimal refinancing exposure, though goodwill rising from $28.7M to $119.6M and deferred revenue reading $0 in 2026Q3 warrant further investigation.

Income StatementBalance SheetCash FlowRatios

CLBT Balance Sheet

Annual statement

CLBT Balance Sheet

Cellebrite DI Ltd. (CLBT) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets658.41M575.85M567.59M422.08M295.93M273.21M324.27M261.88M
Cash & Short-Term Investments483.87M437.05M447.22M302.92M183.62M181.56M237.64M200.25M
Cash Only223.06M124.46M191.66M189.52M87.64M145.97M128.71M76.55M
Short-Term Investments260.81M312.59M255.56M113.41M95.98M35.59M108.93M123.71M
Accounts Receivable139.82M104.97M82.36M77.27M78.76M67.5M66.32M44.24M
Days Sales Outstanding72.7480.5574.9386.75106.22100.06124.293.95
Inventory7.51M7.6M8.94M9.94M10.18M6.51M4.75M3.96M
Days Inventory Outstanding29.7136.9252.1368.1673.1955.8445.8140.35
Other Current Assets5.84M6.59M18.18M23.06M14.77M7.88M11.24M8.86M
Total Non-Current Assets410.07M363M122.97M123.86M107.36M66.57M40.12M18.36M
Property, Plant & Equipment43.58M38.52M27.6M30.16M32.91M16.76M16.11M14.82M
Fixed Asset Turnover13.22x12.35x14.54x10.78x8.22x14.70x12.10x11.59x
Goodwill119.56M119.56M28.71M26.83M26.83M26.83M9.46M0
Intangible Assets117.93M81.47M11.31M10.59M11.25M11.23M6.61M0
Long-Term Investments416.05M97.96M36.6M28.86M22.13M000
Other Non-Current Assets19.59M14.62M7.68M12.89M1.73M1.96M565K447K
Total Assets1.07B938.85M690.57M532.88M403.29M339.78M364.39M280.24M
Asset Turnover0.54x0.51x0.58x0.61x0.67x0.72x0.53x0.61x
Asset Growth %124.44%35.95%29.59%32.13%18.69%-6.75%30.03%-
Total Current Liabilities395.45M369.66M295.5M253.82M207.78M186.57M159.38M99.16M
Accounts Payable20.47M16.83M11.08M8.28M4.61M9.55M4.73M5.36M
Days Payables Outstanding63.4881.7464.5956.7933.1781.8745.5554.61
Short-Term Debt00000000
Deferred Revenue (Current)796.69M278.24M217.64M196.59M153.34M123.68M106.1M69.79M
Other Current Liabilities368.86M009.04M0000
Current Ratio1.66x1.56x1.92x1.66x1.42x1.46x2.03x2.64x
Quick Ratio1.65x1.54x1.89x1.62x1.38x1.43x2.00x2.60x
Cash Conversion Cycle38.9835.7362.4698.12146.2474.03124.4679.69
Total Non-Current Liabilities93.73M84.88M59.05M244.85M121.65M226.56M141.2M122.25M
Long-Term Debt00000000
Capital Lease Obligations71.61M18.67M6.84M9.16M10.35M000
Deferred Tax Liabilities00000000
Other Non-Current Liabilities76.49M16.68M6.95M188.59M69.13M190.13M107.76M103.32M
Total Liabilities489.18M454.53M354.55M498.67M329.43M413.13M300.58M221.41M
Total Debt23.35M22.67M10.97M14.13M15.36M000
Net Debt-199.7M-101.79M-180.69M-175.39M-72.29M-145.97M-128.71M-76.55M
Debt / Equity0.04x0.05x0.03x0.41x0.21x---
Debt / EBITDA0.25x0.29x0.16x0.33x1.50x---
Net Debt / EBITDA-2.13x-1.30x-2.68x-4.06x-7.06x-7.01x-8.53x-29.91x
Interest Coverage---0.79x-811.47x538.94x8.01x4.39x
Total Equity579.31M484.32M336.02M34.21M73.86M-73.35M63.8M58.83M
Equity Growth %145.74%44.13%882.17%-53.68%200.71%-214.96%8.46%-
Book Value per Share2.281.941.600.180.38-0.450.340.31
Total Shareholders' Equity579.31M484.32M336.02M34.21M73.86M-73.35M63.8M58.83M
Common Stock00000000
Retained Earnings-42.57M-86.54M-164.86M118.14M199.24M78.44M28.34M32.56M
Treasury Stock-85K-85K-85K-85K-85K-85K-85K0
Accumulated OCI-804K2.22M2.09M1.05M331K1.37M1.32M804K
Minority Interest00000000

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Volatile liquidity and deferred revenue

Balance Sheet Strengthening Through Accumulated Earnings

According to reported quarterly balance sheets, CLBT's total assets expanded from $556.6M in 2024Q2 to $1.1B in 2026Q3, while retained earnings improved from a deficit of $184.1M to $42.6M, suggesting a materially strengthened equity base over the period.

The shift from a negative equity position in 2024Q2 to $579.3M of equity by 2026Q3 appears driven mainly by sustained net income and capital inflows rather than balance sheet restructuring. The narrowing accumulated deficit suggests the business is beginning to generate retained profits, although the magnitude of asset growth partly reflects cash build and acquired goodwill, which investors should monitor for quality.

Negligible Leverage Limits Refinancing Exposure

Based on reported figures, CLBT carried total debt of only $23.4M against $579.3M of equity in 2026Q3, yielding a debt-to-equity ratio of roughly 0.04, which indicates minimal reliance on borrowed capital.

Debt has remained in a narrow $10.6M to $23.4M range across the period, suggesting leverage is not a strategic lever for growth and that refinancing risk is limited. The low leverage implies that cash flow durability is not constrained by debt service, though the small debt base also means the company has little use for its balance sheet capacity beyond operating needs.

Cash Buffer Remains Volatile Quarter to Quarter

As reported in the quarterly filings, CLBT's cash balance swung from $124.5M at year-end 2025 to $281.4M in 2025Q3 and back to $223.1M in 2026Q3, with the current ratio holding between 1.53 and 2.11 across the period.

A current ratio consistently above 1.5 suggests short-term obligations are comfortably covered, though the quarterly cash swings point to timing effects tied to collections and billing rather than a stable structural reserve. Investors should monitor whether the lower cash points in late 2025 and early 2026 reflect working capital absorption that could recur.

Goodwill Step-Up Inflates Asset Base

Based on reported balance sheets, CLBT's goodwill rose from $28.7M to $119.6M between 2025Q2 and 2025Q4, a roughly fourfold increase that accounts for a meaningful share of the expansion in total assets.

The jump in goodwill appears to reflect an acquisition-related step-up, which lifts asset values without adding tangible productive capacity, and tangible PPE of roughly $40M is modest relative to total assets. This asset mix suggests an asset-light model where impairment risk on the acquired goodwill warrants monitoring if integration underperforms.

Deferred Revenue Signals Subscription Base Durability

According to reported quarterly figures, CLBT's deferred revenue grew from $226.3M in 2024Q2 to $327.8M in 2025Q4 before reading $0 in 2026Q3, a data gap that prevents confident read-through on forward billings.

The steady build in deferred revenue through 2025 suggests a growing contracted, billed-in-advance customer base consistent with the subscription transition. The unavailable 2026Q3 reading means the most recent forward indicator cannot be verified from the supplied data, so this should be treated as unresolved rather than as evidence of contraction.

Goodwill and Working Capital Flatter Headline Strength

Based on reported figures, a substantial part of CLBT's asset growth and quarterly cash variability appears linked to goodwill additions and working capital timing rather than organic cash generation, which may make headline balance sheet strength look better than underlying conditions.

Because goodwill increased by roughly $91M in a single step while cash moved sharply with billing cycles, the reported equity and asset expansion may overstate the durability of the earnings base. Investors should look through to free cash flow conversion and stock-based compensation, which as reported contributed material non-cash add-backs, before treating the balance sheet as fully self-funding.

CLBT — Frequently Asked Questions

Quick answers to the most common questions about buying CLBT stock.

What are the total assets of Cellebrite DI Ltd. (CLBT)?

As of 2025, Cellebrite DI Ltd. (CLBT) had total assets of $938.9M including $575.9M in current assets.

How much debt does Cellebrite DI Ltd. (CLBT) have?

Cellebrite DI Ltd. (CLBT) carries total debt of $22.7M, offset by $437.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cellebrite DI Ltd.?

Cellebrite DI Ltd. (CLBT) has total shareholders' equity (book value) of $484.3M ($1.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cellebrite DI Ltd.'s current ratio and liquidity?

Cellebrite DI Ltd. (CLBT) reported a current ratio of 1.56x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.